The increasing focus on cervical cancer prevention is driving demand for HPV testing, but the market also faces several challenges. Limited screening awareness in low- and middle-income countries, high costs associated with advanced molecular diagnostic tests, and disparities in laboratory infrastructure can restrict access to timely diagnosis. Social stigma surrounding sexually...

Cervical cancer remains one of the most prevalent cancers affecting women worldwide, creating a significant demand for effective screening and early detection solutions. Increasing awareness regarding preventive healthcare, advancements in diagnostic technologies, and government-led screening initiatives are contributing to the expansion of the cervical cancer screening market. Healthcare...